EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update.
EZZ Life Science Holdings Ltd. has reported no material deviation in its full year 2024 earnings from market expectations, despite not issuing any earnings guidance or being covered by analysts. The company experienced significant growth with a 78.9% increase in revenue and over 90% growth in net profit after tax compared to the previous year. Ongoing disclosures throughout the year had kept the market apprised of positive financial developments.
For further insights into AU:EZZ stock, check out TipRanks’ Stock Analysis page.